{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.604","meta":{"versionId":"11","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604","version":"20210306","name":"Serotonin Receptor Antagonist","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.139"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.138"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.137"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.141"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.140"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.136"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.135"]}]},"expansion":{"identifier":"urn:uuid:ab94cb70-16f0-4995-919d-6c0dc9bae379","timestamp":"2022-06-10T11:57:26-04:00","total":28,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"104894","display":"ondansetron 4 MG Disintegrating Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1314133","display":"2 ML ondansetron 2 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1728050","display":"1.5 ML palonosetron 0.05 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1728055","display":"5 ML palonosetron 0.05 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1734399","display":"1 ML granisetron 1 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1740467","display":"2 ML ondansetron 2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1790812","display":"0.625 ML dolasetron mesylate 20 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1790818","display":"5 ML dolasetron mesylate 20 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1810484","display":"0.4 ML granisetron 25 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1947301","display":"2 ML palonosetron 0.125 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"198052","display":"ondansetron 4 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"200101","display":"dolasetron mesylate 20 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2056929","display":"5 ML palonosetron 0.05 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"240912","display":"granisetron 1 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"283504","display":"ondansetron 2 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"310006","display":"dolasetron 100 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"310007","display":"dolasetron 50 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"310599","display":"granisetron 1 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312084","display":"ondansetron 24 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312085","display":"ondansetron 0.8 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312086","display":"ondansetron 8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312087","display":"ondansetron 8 MG Disintegrating Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"543218","display":"1 ML granisetron 0.1 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"692695","display":"ondansetron 16 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"805448","display":"palonosetron 0.5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"825003","display":"168 HR granisetron 0.129 MG/HR Transdermal System"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"998028","display":"ondansetron 8 MG Oral Film"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"998033","display":"ondansetron 4 MG Oral Film"}]}}